Back
Trevi Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
TRVI
Trevi Therapeutics, Inc.
Last Price:
$12.83
Seasonality Move:
59.04%
7 Day Trial
ALL ACCESS PASS
$
7
Trevi Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Trevi Therapeutics, Inc. has on average historically risen by 71.5% based on the past 6 years of stock performance.
-
Trevi Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Trevi Therapeutics, Inc. Stock Undervalued?The current Trevi Therapeutics, Inc. [TRVI] share price is $12.85. The Score for TRVI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
TRVI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Trevi Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Trevi Therapeutics, Inc. has on average historically risen by 71.5% based on the past 6 years of stock performance.
Trevi Therapeutics, Inc. Stock Rating
Buy
52
Trevi Therapeutics, Inc. (TRVI)
is a Buy
Is Trevi Therapeutics, Inc. overpriced?
-
Trevi Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Trevi Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
trevitherapeutics.com
52-Week Data
52-Week High:
14.39
52-Week Low:
3.47
Prediction Charts
Market Cap:
1.6B
Price in USD:
12.85
Volume:
1.2M
Beta:
0.53
Technical Analysis
SMA50:
11.86
SMA100:
10.09
SMA200:
8.26
52-Wk Change:
205.23%
Stock Predictions
-
Is Trevi Therapeutics, Inc. stock public?Yes, Trevi Therapeutics, Inc. is a publicly traded company.
-
What is the Trevi Therapeutics, Inc. stock quote today?The Trevi Therapeutics, Inc. stock price is 12.85 USD today.
-
How to buy Trevi Therapeutics, Inc. stock online?You can buy Trevi Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-8 | 13.66 | 12.98 | 13.66 | 12.85 |
| Dec-9 | 13.25 | 12.99 | 13.45 | 12.94 |
| Dec-10 | 13.07 | 14.17 | 14.39 | 12.92 |
| Dec-11 | 14.00 | 13.17 | 14.16 | 13.10 |
| Dec-12 | 13.12 | 12.77 | 13.45 | 12.71 |
| Dec-15 | 12.88 | 12.61 | 13.01 | 12.49 |
| Dec-16 | 12.52 | 12.41 | 12.93 | 12.39 |
| Dec-17 | 12.41 | 12.11 | 12.62 | 11.91 |
| Dec-18 | 12.25 | 12.19 | 12.51 | 12.02 |
| Dec-19 | 12.48 | 13.01 | 13.22 | 12.28 |
| Dec-22 | 12.98 | 12.74 | 13.16 | 12.68 |
| Dec-23 | 12.64 | 12.82 | 13.10 | 12.50 |
| Dec-24 | 12.73 | 12.97 | 13.19 | 12.73 |
| Dec-26 | 12.92 | 12.85 | 13.16 | 12.60 |
Trevi Therapeutics, Inc. Earnings
Trevi Therapeutics, Inc. Earnings Report: Per Share Trevi Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Trevi Therapeutics, Inc. Forecast Revenue Growth
Trevi Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Trevi Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.10 per share.
* Trevi Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.